| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9703061AFR2760639B1 (en) | 1997-03-14 | 1997-03-14 | MINERALO-VITAMIN THERAPEUTIC ASSOCIATION IN THE FORM OF A UNITABLE ORAL LIQUID PREPARATION |
| EP98913826AEP0971719A1 (en) | 1997-03-14 | 1998-03-04 | Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| CA002283691ACA2283691A1 (en) | 1997-03-14 | 1998-03-04 | Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| EA199900830AEA199900830A1 (en) | 1997-03-14 | 1998-03-04 | THERAPEUTIC MINERALOVITAMIN ASSOCIATION IN THE FORM OF UNITARY LIQUID PREPARATION FOR DRINKING |
| JP54018498AJP2001521495A (en) | 1997-03-14 | 1998-03-04 | Therapeutic combinations of minerals and vitamins in a single formulation of beverage liquid |
| PCT/FR1998/000425WO1998041217A1 (en) | 1997-03-14 | 1998-03-04 | Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| CN98803347ACN1250374A (en) | 1997-03-14 | 1998-03-04 | Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9703061AFR2760639B1 (en) | 1997-03-14 | 1997-03-14 | MINERALO-VITAMIN THERAPEUTIC ASSOCIATION IN THE FORM OF A UNITABLE ORAL LIQUID PREPARATION |
| Publication Number | Publication Date |
|---|---|
| FR2760639A1 FR2760639A1 (en) | 1998-09-18 |
| FR2760639B1true FR2760639B1 (en) | 2000-09-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9703061AExpired - Fee RelatedFR2760639B1 (en) | 1997-03-14 | 1997-03-14 | MINERALO-VITAMIN THERAPEUTIC ASSOCIATION IN THE FORM OF A UNITABLE ORAL LIQUID PREPARATION |
| Country | Link |
|---|---|
| EP (1) | EP0971719A1 (en) |
| JP (1) | JP2001521495A (en) |
| CN (1) | CN1250374A (en) |
| CA (1) | CA2283691A1 (en) |
| EA (1) | EA199900830A1 (en) |
| FR (1) | FR2760639B1 (en) |
| WO (1) | WO1998041217A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITFI970184A1 (en)* | 1997-07-30 | 1999-01-30 | Menarini Farma Ind | PHARMACEUTICAL COMPOSITIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PREPARATION AND THERAPEUTIC USE |
| DE102004051879A1 (en)* | 2004-10-26 | 2006-04-27 | Bayerl, Wolfgang P., Dr. | Curing agent, useful e.g. for the prophylaxis and therapy of osteoporosis, as food auxiliary agent intended to stimulate bone formation, comprises a combination of silicon dioxide with natural minerals and vitamin D |
| GB0507167D0 (en)* | 2005-04-08 | 2005-05-18 | Glaxosmithkline Consumer Healt | Composition |
| JP5303276B2 (en)* | 2005-10-12 | 2013-10-02 | プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー | Methods and products for treating 25-hydroxyvitamin D deficiency and deficiency |
| CN102232967A (en)* | 2010-04-21 | 2011-11-09 | 武汉同济现代医药有限公司 | Novel oral effervescent agent for calcium supply and preparation method thereof |
| WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1062389B (en)* | 1958-02-11 | 1959-07-30 | Wander Ag Dr A | Process for the preparation of sterile vitamin D solutions containing calcium salts |
| US4737375A (en)* | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
| GB8622025D0 (en)* | 1986-09-12 | 1986-10-22 | Beecham Group Plc | Composition |
| DK159807C (en)* | 1989-02-27 | 1992-06-29 | Gunnar Kjems | APPLICATION OF CALCIUM-SUSTAINABLE EMULSIONS FOR THE PREPARATION OF ORAL AGENTS FOR PREVENTION OR TREATMENT OF CALCIUM LACK OF Cattle, especially by calving fever |
| CZ236793A3 (en)* | 1991-05-06 | 1994-04-13 | Procter & Gamble | Combined complement containing calcium and vitamin d |
| FR2724844B1 (en)* | 1994-09-23 | 1997-01-24 | Innothera Lab Sa | VITAMIN-CALCIUM THERAPEUTIC COMBINATION, PROCESS FOR OBTAINING SAME AND USE THEREOF |
| CA2217264A1 (en)* | 1995-04-07 | 1996-10-10 | Abbott Laboratories | Calcium supplements and calcium containing beverages comprising vitamin d |
| Publication number | Publication date |
|---|---|
| WO1998041217A1 (en) | 1998-09-24 |
| FR2760639A1 (en) | 1998-09-18 |
| EA199900830A1 (en) | 2000-04-24 |
| EP0971719A1 (en) | 2000-01-19 |
| CN1250374A (en) | 2000-04-12 |
| JP2001521495A (en) | 2001-11-06 |
| CA2283691A1 (en) | 1998-09-24 |
| Publication | Publication Date | Title |
|---|---|---|
| CY2007001I1 (en) | MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES | |
| DE69916922D1 (en) | Medicinal preparation containing ibuprofen | |
| LU91372I2 (en) | Retapamulin optionally in the form of a pharmaceutically acceptable salt (altargo) | |
| EE200000395A (en) | Oral pharmaceutical pulsatile dosage form | |
| IL118076A0 (en) | Use of retinoids in a cosmetic composition or for the manufacture of a pharmaceutical composition | |
| FI971188L (en) | Therapeutic vitamin-calcium combination in unit dose form in the form of a galenic tablet, method for its preparation and use | |
| FR2760639B1 (en) | MINERALO-VITAMIN THERAPEUTIC ASSOCIATION IN THE FORM OF A UNITABLE ORAL LIQUID PREPARATION | |
| FR2755370B1 (en) | CLEANING COMPOSITION IN THE FORM OF A RINSABLE TRANSPARENT GEL | |
| GB9408053D0 (en) | Pharmaceutical preparation | |
| ZA982073B (en) | Pharmaceutical preparation | |
| PL337807A1 (en) | Sertralin dosage formulation in the form of a gelatine-encapsulated solution | |
| ZA982952B (en) | Pseudo-peptide compounds their preparation and use in pharmaceutical formulations | |
| PL332783A1 (en) | Pharmaceutic preparation in the form of gel | |
| FR2797766B1 (en) | NEW TOPICAL FORMS WITH A PASTY CONSISTENCY IN THE FORM OF A GEL DISTRIBUTED IN DOSES | |
| ZA952013B (en) | Pharmaceutical preparation | |
| FR2743721B1 (en) | MINERAL-PHYTOTHERAPIC ASSOCIATION IN UNITARY GALENIC FORM OF TABLETS | |
| FI951041L (en) | Use of (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide in the manufacture of a pharmaceutical preparation for the treatment of anxiety | |
| UA1958S (en) | PACKAGING OF THE MEDICAL PREPARATION "ASPARKAM" | |
| UA1954S (en) | PACKAGING OF THE MEDICAL PREPARATION "DIMEXID" | |
| UA2094S (en) | LABEL OF THE MEDICINAL PREPARATION "ASPARKAM" | |
| UA1957S (en) | LABEL OF THE MEDICINAL PREPARATION "ASPARKAM" | |
| UA1951S (en) | LABEL OF THE MEDICINAL PREPARATION "VALIDOL" | |
| GB9711839D0 (en) | Improvements in or relating to diagnostic/therapeutic agents | |
| GB9700699D0 (en) | Improvements in or relating to diagnostic/therapeutic agents | |
| GB9711846D0 (en) | Improvements in or relating to diagnostic/therapeutic agents |
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |